Sheila Maria Barbosa de Lima
Overview
Explore the profile of Sheila Maria Barbosa de Lima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silva-Fernandes A, Moreira S, Gaspar L, Cajaraville A, Simoes M, Pereira R, et al.
Vaccine
. 2025 Jan;
48:126721.
PMID: 39826431
Yellow fever (YF) is a viral disease that affects both humans and non-human primates (NHPs). Neotropical monkeys are more severely stricken by YF and the impact of the disease can...
2.
Venancio F, Quiliao M, Gabeira S, Carvalho A, Leite S, de Lima S, et al.
Pediatrics
. 2025 Jan;
155(2).
PMID: 39814049
Background: Zika virus (ZIKV) infection during pregnancy can lead to congenital Zika syndrome (CZS) and may result in neurodevelopmental alterations in exposed children, with and without CZS. This study aimed...
3.
Teixeira C, Dias J, Morgado-Santos L, da Costa-Rocha I, Giarola-Silva S, Lopes-Ribeiro A, et al.
Inflamm Res
. 2025 Jan;
74(1):16.
PMID: 39797999
Introduction: The present study aimed at evaluating the systemic profile and network connectivity of immune mediators during acute chikungunya fever (CHIKF) according to days of symptoms onset and ageing. Methods:...
4.
Machado K, da Costa-Rocha I, Aguiar L, Moulaz I, Miyamoto S, Costa Martins P, et al.
Hum Vaccin Immunother
. 2024 Jul;
20(1):2318814.
PMID: 38961639
The present study aimed at investigating whether the hydroxychloroquine (HCQ) treatment would impact the neutralizing antibody production, viremia levels and the kinetics of serum soluble mediators upon planned 17DD-Yellow Fever...
5.
Caetano D, Toledo T, de Lima A, Giacoia-Gripp C, de Almeida D, de Lima S, et al.
Vaccines (Basel)
. 2024 Jun;
12(6).
PMID: 38932307
The yellow fever (YF) vaccine is one of the safest and most effective vaccines currently available. Still, its administration in people living with HIV (PLWH) is limited due to safety...
6.
Vianna C, Noronha T, Camacho L, Andrade R, de Souza Brum R, Dos Santos E, et al.
Vaccine
. 2024 Jun;
42(24):126083.
PMID: 38926068
A single dose of standard yellow fever (YF) vaccine is considered to provide life-long protection. In this study, we evaluate the seropositivity conferred by lower doses 10 years post-vaccination. In...
7.
Reis L, Costa-Rocha I, Abdala-Torres T, Campi-Azevedo A, Peruhype-Magalhaes V, Araujo M, et al.
Sci Rep
. 2024 Apr;
14(1):7709.
PMID: 38565882
The present study aimed at evaluating the YF-specific neutralizing antibody profile besides a multiparametric analysis of phenotypic/functional features of cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF vaccine,...
8.
Rodrigues C, Caroline Ribeiro Sales A, Sartori A, Azevedo A, de Lima S, Picone C, et al.
Vaccine
. 2024 Mar;
42(11):2729-2732.
PMID: 38514353
Studies on yellow fever vaccine (YF) in chronic kidney disease (CKD) patients are scarce. This cross-sectional study aimed to evaluate YF neutralizing antibody seroprevalence and titers in previously vaccinated adults...
9.
Abdala-Torres T, Campi-Azevedo A, da Silva-Pereira R, Dos Santos L, Henriques P, Costa-Rocha I, et al.
NPJ Vaccines
. 2024 Mar;
9(1):54.
PMID: 38459059
The re-emergence of yellow fever (YF) urged new mass vaccination campaigns and, in 2017, the World Health Organization approved the use of the fractional dose (FD) of the YF vaccine...
10.
Horbach I, Azevedo A, Schwarcz W, Alves N, de Moura Dias B, Setatino B, et al.
Diseases
. 2024 Jan;
12(1).
PMID: 38248380
Massive vaccination positively impacted the SARS-CoV-2 pandemic, being a strategy to increase the titers of neutralizing antibodies (NAbs) in the population. Assessing NAb levels and understanding the kinetics of NAb...